Prevep, Inc.

Bethesda, MD

UEI
PVCMPWKKBCV8
CAGE
8D2B2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6410 Rockledge Dr #610, Bethesda, MD 20817, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate. R43NS132659 National Institute of Neurological Disorders and Stroke (NIH) $702,512
Network pharmacology for epilepsy prevention R43NS119081 National Institute of Neurological Disorders and Stroke (NIH) $1,689,896

Quick answers

Is Prevep, Inc. registered in SAM.gov?

Yes. Prevep, Inc.'s SAM.gov registration is active through February 12, 2027.

What is Prevep, Inc.'s most recent federal award?

Prevep, Inc.'s most recent federal grant award is Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate (R43NS132659), from National Institute of Neurological Disorders and Stroke (NIH), on September 21, 2023.

On GovTribe

See Prevep, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login